[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EVANS et al., 1957 - Google Patents

The serology of autoimmune hemolytic disease: observations on forty-one patients

EVANS et al., 1957

Document ID
18277818195580686079
Author
EVANS R
WEISER R
Publication year
Publication venue
AMA archives of internal medicine

External Links

Snippet

Introduction During the past 10 years new and improved serological techniques have permitted the demonstration and characterization of the antibodies of acquired hemolytic anemia even though little is known about their genesis. The antibodies of this disease …
Continue reading at jamanetwork.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood

Similar Documents

Publication Publication Date Title
EVANS et al. The serology of autoimmune hemolytic disease: observations on forty-one patients
Wiener et al. Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions: biologic test with bovine red cells
SHAW et al. Infection and immunity in chronic lymphocytic leukemia
Meuwissen et al. Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow: crucial role of histocompatibility matching
Jandl et al. The destruction of red cells by antibodies in man. I. Observations on the sequestration and lysis of red cells altered by immune mechanisms
Dausset et al. Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (Anti-Tn)
Wiener Competition of Antigens in Isoimmunization by Pregnancy.
Harboe et al. Synthesis of donor type γG‐globulin following thymus transplantation in hypo‐γ‐globulinaemia with severe lymphocytopenia
Svejgaard et al. Complement-fixing platelet iso-antibodies
Wiener Subdivisions of Group A and Group AB: II. Isoimmunization of A2 Individuals Against A1 Blood; with Special Reference to the Rôle of the Subgroups in Transfusion Reactions
Lalezari et al. Identification of a specific leukocyte antigen: another presumed example of 5b
Mogensen et al. Histocompatibility antigens on the HL-A locus in generalised gestational choriocarcinoma: a family study
O'Connell et al. Absence of activity of first component of complement in man: association with thymic alymphoplasia and defective inflammatory response
LALEZARI et al. Studies on the genetics of leukocyte antigens
Chan‐Shu et al. A new method of antibody elution from red blood cells
Lapin et al. An improved method for isolating viable human leukocytes from peripheral blood
Wasnik et al. Blood group discrepancy in a whole blood donor with weak AB
Eisner et al. Quinidine-induced agranulocytosis
Bialek et al. Distribution and quantity of leukocyte antigens in the formed elements of the blood
Hutchinson et al. Advantages of use of maternal erythrocytes for fetal transfusion
Neter Observations on abnormal isoantibodies following transfusions
Fong et al. Characterization of maternal isoagglutinins in ABO hemolytic disease of the newborn
Ottensooser et al. Fatal transfusion reaction due to the Kell factor
Noor et al. Determination of ABO antibody titre and haemolysin test of group O whole blood used for exchanged transfusion in a teaching hospital
Heard The recognition of four red cell antigen-antibody systems in the rabbit